These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 18691139)

  • 21. Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.
    Gómez-Acevedo H; Li MY; Jacobson S
    Bull Math Biol; 2010 Apr; 72(3):681-96. PubMed ID: 20041353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
    Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
    Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis.
    Gois LL; Ribeiro-Soares B; Regis-Silva CG; Zanette DL; Lisboa R; Nascimento RS; Coutinho Junior R; Galvão-Castro B; Grassi MFR
    BMC Infect Dis; 2024 Jun; 24(1):652. PubMed ID: 38943078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
    Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S
    Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease.
    Enose-Akahata Y; Matsuura E; Tanaka Y; Oh U; Jacobson S
    Retrovirology; 2012 Feb; 9():16. PubMed ID: 22335964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
    Best I; López G; Talledo M; MacNamara A; Verdonck K; González E; Tipismana M; Asquith B; Gotuzzo E; Vanham G; Clark D
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1207-12. PubMed ID: 21453202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
    Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
    Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
    Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
    AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.
    Tanaka M; Takenouchi N; Arishima S; Matsuzaki T; Nozuma S; Matsuura E; Takashima H; Kubota R
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
    Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E
    J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
    Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
    Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Otaguiri KK; Dos Santos DF; Slavov SN; Depieri LV; Palma PVB; Meirelles FV; Covas DT; da Silveira JC; Kashima S
    AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1075-1082. PubMed ID: 30229663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.
    Nagai M; Yamano Y; Brennan MB; Mora CA; Jacobson S
    Ann Neurol; 2001 Dec; 50(6):807-12. PubMed ID: 11761481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease.
    Enose-Akahata Y; Oh U; Grant C; Jacobson S
    Blood; 2008 Sep; 112(6):2400-10. PubMed ID: 18509087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Starling AL; Martins-Filho OA; Lambertucci JR; Labanca L; de Souza Pereira SR; Teixeira-Carvalho A; Martins ML; Ribas JG; Carneiro-Proietti AB; Gonçalves DU
    Acta Trop; 2013 Jan; 125(1):75-81. PubMed ID: 23022356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
    Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
    J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.